{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:02:17Z","timestamp":1771034537278,"version":"3.50.1"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deb Bailey Foundation"},{"name":"MND and Me Foundation"},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuro.2018.02.017","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T10:37:04Z","timestamp":1519987024000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Myxobacterial natural products: An under-valued source of products for drug discovery for neurological disorders"],"prefix":"10.1016","volume":"66","author":[{"given":"Mona","family":"Dehhaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Mohammadipanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2018.02.017_bib0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/ol800061h","article-title":"Sorangiadenosine, a new sesquiterpene adenoside from the myxobacterium Sorangium cellulosum","volume":"10","author":"Ahn","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.neuro.2018.02.017_bib0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.325.7370.932","article-title":"Fish, meat, and risk of dementia: cohort study","volume":"325","author":"Barberger-Gateau","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.neuro.2018.02.017_bib0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/anie.201106435","article-title":"Isolation and total synthesis of icumazoles and noricumazoles\u2014antifungal antibiotics and cation-channel blockers from Sorangium cellulosum","volume":"51","author":"Barbier","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuro.2018.02.017_bib0020","unstructured":"Baumann, S., et al., 2014a. Cystobactamides. Google Patents."},{"key":"10.1016\/j.neuro.2018.02.017_bib0025","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1002\/ange.201409964","article-title":"Cystobactamide: Topoisomerase\u2010Inhibitoren aus Myxobakterien mit hoher antibakterieller Aktivit\u00e4t","volume":"126","author":"Baumann","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.neuro.2018.02.017_bib0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuro.2018.02.017_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10295-006-0082-7","article-title":"Analysis of myxobacterial secondary metabolism goes molecular","volume":"33","author":"Bode","year":"2006","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0040","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/(SICI)1099-0690(199910)1999:10<2601::AID-EJOC2601>3.0.CO;2-#","article-title":"Melithiazols A\u2013N: new antifungal \u03b2\u2010methoxyacrylates from myxobacteria","volume":"1999","author":"B\u00f6hlendorf","year":"1999","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.neuro.2018.02.017_bib0045","series-title":"Combinatorial Synthesis of Natural Product-Based Libraries","author":"Boldi","year":"2006"},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0050","first-page":"2325","article-title":"Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action","volume":"55","author":"Bollag","year":"1995","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0304-4165(73)90148-7","article-title":"Adult rat brain synaptic vesicles II. Lipid composition","volume":"320","author":"Breckenridge","year":"1973","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subjects"},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1099\/mic.0.28335-0","article-title":"Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes","volume":"152","author":"Busti","year":"2006","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/b402985m","article-title":"Natural products to drugs: natural product derived compounds in clinical trials","volume":"22","author":"Butler","year":"2005","journal-title":"Nat. Prod. Rep."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1039\/b514294f","article-title":"Natural products to drugs: natural product-derived compounds in clinical trials","volume":"25","author":"Butler","year":"2008","journal-title":"Nat. Prod. Rep."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"14","key":"10.1016\/j.neuro.2018.02.017_bib0080","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1039\/C4CC08798D","article-title":"Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry","volume":"51","author":"Cagide","year":"2015","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","article-title":"Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer\u2019s disease","volume":"22","author":"Calon","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer\u2019s disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-4159.2009.06335.x","article-title":"Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function","volume":"111","author":"Cao","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2018.02.017_bib0100","first-page":"3","article-title":"Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective","author":"Cartelli","year":"2013","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molimm.2015.07.025","article-title":"Microbe-associated immunomodulatory metabolites: influence on T cell fate and function","volume":"68","author":"Castro","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuro.2018.02.017_bib0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nbd.2009.05.006","article-title":"Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies","volume":"35","author":"Chiorazzi","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0115","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro3178","article-title":"Bacterial solutions to multicellularity: a tale of biofilms, filaments and fruiting bodies","volume":"12","author":"Claessen","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.plefa.2009.05.015","article-title":"Omega-3 fatty acids and dementia","volume":"81","author":"Cole","year":"2009","journal-title":"Prostaglandins Leukotrienes Essent. Fatty Acids"},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/anie.201106305","article-title":"Myxoprincomide: a natural product from Myxococcus xanthus discovered by comprehensive analysis of the secondary metabolome","volume":"51","author":"Cortina","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0135","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.neuro.2018.02.017_bib0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbamem.2010.10.014","article-title":"Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing","volume":"1808","author":"Eckert","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.plefa.2012.05.006","article-title":"Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria","volume":"88","author":"Eckert","year":"2013","journal-title":"Prostaglandins Leukotrienes Essent. Fat. Acids (PLEFA)"},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0155","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/cbic.201000085","article-title":"Biosynthesis of the myxobacterial antibiotic corallopyronin A","volume":"11","author":"Erol","year":"2010","journal-title":"ChemBioChem"},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0160","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1021\/ol500779s","article-title":"Cystomanamides: Structure and biosynthetic pathway of a family of glycosylated lipopeptides from Myxobacteria","volume":"16","author":"Etzbach","year":"2014","journal-title":"Org. Lett."},{"issue":"28","key":"10.1016\/j.neuro.2018.02.017_bib0165","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1002\/chem.201301379","article-title":"Salimabromide: unexpected chemistry from the obligate marine myxobacterium Enhygromxya salina","volume":"19","author":"Felder","year":"2013","journal-title":"Chem.-Eur. J."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0170","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/cbic.201300268","article-title":"Salimyxins and enhygrolides: antibiotic, sponge\u2010related metabolites from the obligate marine Myxobacterium Enhygromyxa salina","volume":"14","author":"Felder","year":"2013","journal-title":"ChemBioChem"},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/ars.2010.3750","article-title":"Maternal docosahexaenoic acid feeding protects against impairment of learning and memory and oxidative stress in prenatally stressed rats: possible role of neuronal mitochondria metabolism","volume":"16","author":"Feng","year":"2012","journal-title":"Antioxid. Redox. Signal."},{"issue":"15","key":"10.1016\/j.neuro.2018.02.017_bib0180","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1074\/jbc.M111738200","article-title":"The biosynthesis of the aromatic myxobacterial electron transport inhibitor stigmatellin is directed by a novel type of modular polyketide synthase","volume":"277","author":"Gaitatzis","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0185","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1021\/cr400265z","article-title":"Chromone: a valid scaffold in medicinal chemistry","volume":"114","author":"Gaspar","year":"2014","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0190","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/np100682c","article-title":"A highly conjugated dihydroxylated C28 steroid from a myxobacterium","volume":"74","author":"Gawas","year":"2011","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0195","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1039\/c3sc53163e","article-title":"Polyunsaturated fatty acid biosynthesis in myxobacteria: different PUFA synthases and their product diversity","volume":"5","author":"Gemperlein","year":"2014","journal-title":"Chem. Sci."},{"issue":"32","key":"10.1016\/j.neuro.2018.02.017_bib0200","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1002\/chem.201602682","article-title":"Total Synthesis Aetheramide A","volume":"22","author":"Gerstmann","year":"2016","journal-title":"Chem.-A Eur. J."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7164\/antibiotics.49.560","article-title":"Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria)","volume":"49","author":"Gerth","year":"1996","journal-title":"J. Antibiot."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7164\/antibiotics.47.23","article-title":"The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria)","volume":"47","author":"Gerth","year":"1994","journal-title":"J. Antibiot."},{"issue":"12","key":"10.1016\/j.neuro.2018.02.017_bib0215","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.7164\/antibiotics.33.1474","article-title":"Myxothiazol, an antibiotic from Myxococcus fulvus (Myxobacterales)","volume":"33","author":"Gerth","year":"1980","journal-title":"J. Antibiot."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0220","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.7164\/antibiotics.35.1454","article-title":"The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales)","volume":"35","author":"Gerth","year":"1982","journal-title":"J. Antibiot."},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0225","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.7164\/antibiotics.36.1150","article-title":"The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales)","volume":"36","author":"Gerth","year":"1983","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jbiotec.2003.07.015","article-title":"Myxobacteria: proficient producers of novel natural products with various biological activities\u2014past and future biotechnological aspects with the focus on the genus Sorangium","volume":"106","author":"Gerth","year":"2003","journal-title":"J. Biotechnol."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/anie.200703993","article-title":"Chlorotonil A, a Macrolide with a Unique gem\u2010Dichloro-1, 3-dione Functionality from Sorangium cellulosum, So ce1525","volume":"47","author":"Gerth","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0240","first-page":"115","article-title":"Properties and architecture of drugs and natural products revisited","volume":"1","author":"Grabowski","year":"2007","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.neuro.2018.02.017_bib0245","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3762\/bjoc.9.293","article-title":"The myxocoumarins A and B from Stigmatella aurantiaca strain MYX-030","volume":"9","author":"Gulder","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10637-014-0185-3","article-title":"The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells","volume":"33","author":"Guzm\u00e1n","year":"2015","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.neuro.2018.02.017_bib0255","series-title":"Halophiles. Sustainable Development and Biodiversity","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-14595-2_3","article-title":"Biotechnological exploitation of Actinobacterial Members","author":"Hamedi","year":"2015"},{"key":"10.1016\/j.neuro.2018.02.017_bib0260","doi-asserted-by":"crossref","first-page":"35441","DOI":"10.1038\/srep35441","article-title":"Enhanced production of polyunsaturated fatty acids by enzyme engineering of tandem acyl carrier proteins","volume":"6","author":"Hayashi","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neuro.2018.02.017_bib0265","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","article-title":"Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050","volume":"15","author":"Hebert","year":"2001","journal-title":"Alzheimer Dis. Assoc. Dis."},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0270","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch. Neurol."},{"issue":"19","key":"10.1016\/j.neuro.2018.02.017_bib0275","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"35","key":"10.1016\/j.neuro.2018.02.017_bib0280","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1002\/anie.201411377","article-title":"Discovery, structure elucidation, and biological characterization of nannocystin A, a macrocyclic myxobacterial metabolite with potent antiproliferative properties","volume":"54","author":"Hoffmann","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"issue":"45","key":"10.1016\/j.neuro.2018.02.017_bib0285","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1021\/ja4054509","article-title":"Microsclerodermins from terrestrial myxobacteria: an intriguing biosynthesis likely connected to a sponge symbiont","volume":"135","author":"Hoffmann","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"36","key":"10.1016\/j.neuro.2018.02.017_bib0290","doi-asserted-by":"crossref","first-page":"11362","DOI":"10.1002\/chem.201201879","article-title":"Isolation, biological activity evaluation, structure elucidation, and total synthesis of Eliamid: a novel complex I inhibitor","volume":"18","author":"H\u00f6fle","year":"2012","journal-title":"Chem.-Eur. J."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0295","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/ijms13011225","article-title":"Disruption of axonal transport in motor neuron diseases","volume":"13","author":"Ikenaka","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0300","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7164\/antibiotics.48.787","article-title":"The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria","volume":"48","author":"Irschik","year":"1995","journal-title":"J. Antibiot."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7164\/antibiotics.40.7","article-title":"The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria","volume":"40","author":"Irschik","year":"1987","journal-title":"J. Antibiot."},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0310","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7164\/antibiotics.48.962","article-title":"Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria","volume":"48","author":"Irschik","year":"1995","journal-title":"J. Antibiot."},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0315","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7164\/antibiotics.48.886","article-title":"Sorangiolid A, a new antibiotic isolated from the myxobacterium Sorangium cellulosum So ce 12","volume":"48","author":"Irschik","year":"1995","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7164\/antibiotics.38.145","article-title":"The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria","volume":"38","author":"Irschik","year":"1985","journal-title":"J. Antibiot."},{"issue":"20","key":"10.1016\/j.neuro.2018.02.017_bib0325","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1002\/anie.201210113","article-title":"Isolation, structure elucidation, and biological activity of maltepolides: remarkable macrolides from Myxobacteria","volume":"52","author":"Irschik","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"issue":"21","key":"10.1016\/j.neuro.2018.02.017_bib0330","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1002\/anie.201200327","article-title":"Pellasoren: structure elucidation, biosynthesis, and total synthesis of a cytotoxic secondary metabolite from Sorangium cellulosum","volume":"51","author":"Jahns","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.neuro.2018.02.017_bib0335","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1021\/np500144t","article-title":"Indothiazinone, an indolyl thiazolyl ketone from a novel myxobacterium belonging to the sorangiineae","volume":"77","author":"Jansen","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0340","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1021\/np400877r","article-title":"Pyrronazols, metabolites from the myxobacteria Nannocystis pusilla and N. exedens, are unusual chlorinated pyrone-oxazole-pyrroles","volume":"77","author":"Jansen","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0345","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/np500632c","article-title":"Nannozinones and sorazinones, unprecedented pyrazinones from myxobacteria","volume":"77","author":"Jansen","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0350","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/(SICI)1099-0690(199905)1999:5<1085::AID-EJOC1085>3.0.CO;2-G","article-title":"The crocacins, novel antifungal and cytotoxic antibiotics from Chondromyces crocatus and Chondromyces pediculatus (myxobacteria): Isolation and structure elucidation","volume":"1999","author":"Jansen","year":"1999","journal-title":"Eur. J. Org. Chem."},{"issue":"14","key":"10.1016\/j.neuro.2018.02.017_bib0355","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1016\/j.bmc.2012.05.043","article-title":"Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC\u2013MS\/ELSD libraries","volume":"20","author":"Johnson","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0360","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","article-title":"Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys","volume":"48","author":"Julien","year":"2006","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12883-016-0732-y","article-title":"Prevalence and incidence of neurological disorders among adult Ugandans in rural and urban Mukono district; a cross-sectional study","volume":"16","author":"Kaddumukasa","year":"2016","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acs.jnatprod.5b00997","article-title":"Sorazolons, Carbazole Alkaloids from Sorangium cellulosum Strain Soce375","volume":"79","author":"Karwehl","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"25","key":"10.1016\/j.neuro.2018.02.017_bib0375","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1021\/jacs.5b03833","article-title":"Macyranones: structure, biosynthesis, and binding mode of an unprecedented epoxyketone that targets the 20S proteasome","volume":"137","author":"Keller","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0380","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2012.10.088","article-title":"Myxobacterial metabolites enhance cell proliferation and reduce intracellular stress in cells from a Parkinson\u2019s disease mouse model","volume":"514","author":"Kim","year":"2013","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0385","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7164\/antibiotics.44.553","article-title":"Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells","volume":"44","author":"Kim","year":"1991","journal-title":"J. Antibiot."},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0390","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1021\/acs.jnatprod.6b00294","article-title":"Isolation of coralmycins A and B, potent anti-Gram negative compounds from the Myxobacteria Corallococcus coralloides M23","volume":"79","author":"Kim","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"35","key":"10.1016\/j.neuro.2018.02.017_bib0395","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1002\/anie.201505069","article-title":"Nannocystin A: an elongation factor 1 inhibitor from myxobacteria with differential anti\u2010cancer properties","volume":"54","author":"Krastel","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0400","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7164\/antibiotics.40.258","article-title":"The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties","volume":"40","author":"Kunze","year":"1987","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7164\/antibiotics.57.151","article-title":"Ajudazols, new inhibitors of the mitochondrial electron transport from Chondromyces crocatus","volume":"57","author":"Kunze","year":"2004","journal-title":"J. Antibiot."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0410","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.7164\/antibiotics.46.1752","article-title":"Thiangazole, a new thiazoline antibiotic from Polyangium sp. (myxobacteria): production, antimicrobial activity and mechanism of action","volume":"46","author":"Kunze","year":"1993","journal-title":"J. Antibiot."},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0415","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.7164\/antibiotics.48.1262","article-title":"Chondramides AD, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (Myxobacteria)","volume":"48","author":"Kunze","year":"1995","journal-title":"J. Antibiot."},{"issue":"12","key":"10.1016\/j.neuro.2018.02.017_bib0420","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.7164\/antibiotics.38.1649","article-title":"Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales)","volume":"38","author":"Kunze","year":"1985","journal-title":"J. Antibiot."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0425","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7164\/antibiotics.35.635","article-title":"Isolation and identification of althiomycin from Cystobacter fuscus (Myxobacterales)","volume":"35","author":"Kunze","year":"1982","journal-title":"J. Antibiot."},{"issue":"14","key":"10.1016\/j.neuro.2018.02.017_bib0430","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1080\/00397911.2015.1040513","article-title":"Studies on the synthesis of Indothiazinone and its derivatives via direct 3-acylation of indole","volume":"45","author":"Kwon","year":"2015","journal-title":"Synth. Commun."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tim.2007.04.001","article-title":"New aspects of natural products in drug discovery","volume":"15","author":"Lam","year":"2007","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/13543784.15.3.211","article-title":"Recent developments in antibacterial drug discovery: microbe-derived natural products\u2013from collection to the clinic","volume":"15","author":"Leeds","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"5937","key":"10.1016\/j.neuro.2018.02.017_bib0445","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: end of an era or an endless frontier?","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0450","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bmc.2015.01.042","article-title":"Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer's disease","volume":"23","author":"Liu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0455","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.npep.2013.10.011","article-title":"Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)","volume":"47","author":"Magen","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuro.2018.02.017_bib0460","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3762\/bjoc.11.184","article-title":"SmI2-mediated dimerization of indolylbutenones and synthesis of the myxobacterial natural product indiacen B","volume":"11","author":"Marsch","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0465","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2859-12-85","article-title":"Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay","volume":"12","author":"Martinez","year":"2013","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0470","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0475","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.ejmech.2011.07.057","article-title":"Natural products: an evolving role in future drug discovery","volume":"46","author":"Mishra","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0480","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-5521(00)00075-2","article-title":"The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90","volume":"7","author":"Molnar","year":"2000","journal-title":"Chem. Biol."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0485","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch. Neurol."},{"issue":"16","key":"10.1016\/j.neuro.2018.02.017_bib0490","first-page":"3344","article-title":"Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity","volume":"57","author":"M\u00fchlradt","year":"1997","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neuro.2018.02.017_bib0495","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/bi052075r","article-title":"Heterologous production of epothilone C and D in Escherichia coli","volume":"45","author":"Mutka","year":"2006","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0500","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1021\/acs.jnatprod.5b00343","article-title":"Cystochromones, unusual chromone-containing polyketides from the Myxobacterium Cystobacter sp.. MCy9104","volume":"78","author":"Nadmid","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"16","key":"10.1016\/j.neuro.2018.02.017_bib0505","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/ol501826a","article-title":"Hyalachelins A\u2013C, unusual siderophores isolated from the terrestrial myxobacterium Hyalangium minutum","volume":"16","author":"Nadmid","year":"2014","journal-title":"Org. Lett."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0510","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1039\/b612668p","article-title":"The chemistry of gliding bacteria","volume":"24","author":"Nett","year":"2007","journal-title":"Nat. Prod. Rep."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0515","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-7012(01)00320-7","article-title":"Biomarker techniques to screen for bacteria that produce polyunsaturated fatty acids","volume":"48","author":"Nichols","year":"2002","journal-title":"J. Microbiol. Methods"},{"issue":"23","key":"10.1016\/j.neuro.2018.02.017_bib0520","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1002\/ejoc.200500425","article-title":"Spirangien A and B, highly cytotoxic and antifungal spiroketals from the myxobacterium Sorangium cellulosum: isolation, structure elucidation and chemical modifications","volume":"2005","author":"Niggemann","year":"2005","journal-title":"Eur. J. Org. Chem."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0525","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ejoc.200300539","article-title":"Tuscolid and Tuscoron A and B: isolation, structural elucidation and studies on the biosynthesis of novel Furan-3 (2H)-one-Containing metabolites from the Myxobacterium Sorangium Cellulosum","volume":"2004","author":"Niggemann","year":"2004","journal-title":"Eur. J. Org. Chem."},{"issue":"18","key":"10.1016\/j.neuro.2018.02.017_bib0530","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/cbic.200800434","article-title":"Phenylnannolones A\u2013C: biosynthesis of new secondary metabolites from the Myxobacterium Nannocystis exedens","volume":"9","author":"Ohlendorf","year":"2008","journal-title":"ChemBioChem"},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0535","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/np500145f","article-title":"Hyafurones, hyapyrrolines, and hyapyrones: polyketides from Hyalangium minutum","volume":"77","author":"Okanya","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.neuro.2018.02.017_bib0540","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/np200776v","article-title":"Hyaladione, an S-methyl cyclohexadiene-dione from Hyalangium minutum","volume":"75","author":"Okanya","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.neuro.2018.02.017_bib0545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","article-title":"Measuring ER stress and the unfolded protein response using mammalian tissue culture system","volume":"490","author":"Oslowski","year":"2011","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0550","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","article-title":"An analysis of FDA-approved drugs: natural products and their derivatives","volume":"21","author":"Patridge","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0555","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/ol3011002","article-title":"Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus \u201cAetherobacter","volume":"14","author":"Plaza","year":"2012","journal-title":"Org. Lett."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1022457605436","article-title":"Regional membrane phospholipid alterations in Alzheimer\u2019s disease","volume":"23","author":"Prasad","year":"1998","journal-title":"Neurochem. Res."},{"issue":"17","key":"10.1016\/j.neuro.2018.02.017_bib0565","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0570","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ja.2014.55","article-title":"Angiolactone, a new Butyrolactone isolated from the terrestrial myxobacterium, Angiococcus sp","volume":"67","author":"Raju","year":"2014","journal-title":"J. Antibiot."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0575","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ja.2015.8","article-title":"Cystodienoic acid: a new diterpene isolated from the myxobacterium Cystobacter sp","volume":"68","author":"Raju","year":"2015","journal-title":"J. Antibiot."},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0580","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1007\/s00044-015-1367-z","article-title":"Inhibition of Alzheimer\u2019s BACE-1 by 2, 6-dialkyl-4-chromon-3-yl-1, 4-dihydropyridine-3, 5-dicarboxylates","volume":"24","author":"Razzaghi-Asl","year":"2015","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0585","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/cbic.201100635","article-title":"The myxobacterial compounds spirangien a and spirangien M522 are potent inhibitors of IL-8 expression","volume":"13","author":"Reboll","year":"2012","journal-title":"ChemBioChem"},{"issue":"3","key":"10.1016\/j.neuro.2018.02.017_bib0590","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jim.7000025","article-title":"Myxobacteria, producers of novel bioactive substances","volume":"27","author":"Reichenbach","year":"2001","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.neuro.2018.02.017_bib0595","series-title":"The Myxobacteria, The Prokaryotes","first-page":"3416","author":"Reichenbach","year":"1992"},{"key":"10.1016\/j.neuro.2018.02.017_bib0600","first-page":"149","article-title":"Myxobacteria as producers of secondary metabolites","author":"Reichenbach","year":"1999","journal-title":"Drug Discov. Nat."},{"issue":"19","key":"10.1016\/j.neuro.2018.02.017_bib0605","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.jmedchem.6b01720","article-title":"Chromone as a privileged scaffold in drug discovery\u2013recent advances","volume":"60","author":"Reis","year":"2017","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.neuro.2018.02.017_bib0610","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7164\/antibiotics.30.371","article-title":"Ambruticin (W7783), a new antifungal antibiotic","volume":"30","author":"Ringel","year":"1977","journal-title":"J. Antibiot."},{"key":"10.1016\/j.neuro.2018.02.017_bib0615","unstructured":"Roemer, E., et al., 2009. Production of omega-3 fatty acids by myxobacteria. Google Patents."},{"key":"10.1016\/j.neuro.2018.02.017_bib0620","series-title":"Myxobacteria: Development and Cell Interactions","author":"Rosenberg","year":"2012"},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0625","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0896-6273(95)90271-6","article-title":"Axonal transport of tubulin in tit pioneer neurons in situ","volume":"14","author":"Sabry","year":"1995","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0630","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease","volume":"287","author":"Saman","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.neuro.2018.02.017_bib0635","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/jnci\/90.20.1559","article-title":"The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton","volume":"90","author":"Sasse","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"48","key":"10.1016\/j.neuro.2018.02.017_bib0640","doi-asserted-by":"crossref","first-page":"15933","DOI":"10.1002\/chem.201404291","article-title":"Structure and biosynthetic assembly of gulmirecins, macrolide antibiotics from the predatory bacterium Pyxidicoccus fallax","volume":"20","author":"Schieferdecker","year":"2014","journal-title":"Chem.-Eur. J."},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0645","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/pr0602489","article-title":"Proteome analysis of Myxococcus x anthus by off-line two-dimensional chromatographic separation using monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass spectrometry","volume":"5","author":"Schley","year":"2006","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0650","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/np400740u","article-title":"Corallorazines from the Myxobacterium Corallococcus coralloides","volume":"77","author":"Schmitz","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0655","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.molcel.2004.11.034","article-title":"A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product","volume":"16","author":"Shen","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuro.2018.02.017_bib0660","series-title":"The Myxobacteria, The Prokaryotes","first-page":"31","author":"Shimkets","year":"2006"},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0665","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02536067","article-title":"Fatty acid composition of brain phospholipids in aging and in Alzheimer\u2019s disease","volume":"26","author":"S\u00f6derberg","year":"1991","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.neuro.2018.02.017_bib0670","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11064-008-9838-y","article-title":"Prenatal stress causes oxidative damage to mitochondrial DNA in hippocampus of offspring rats","volume":"34","author":"Song","year":"2009","journal-title":"Neurochem. Res."},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0675","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/np300288b","article-title":"Indiacens A and B: prenyl indoles from the myxobacterium Sandaracinus amylolyticus","volume":"75","author":"Steinmetz","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0680","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/molecules21010059","article-title":"Isolation and biosynthetic analysis of haliamide, a new PKS-NRPS hybrid metabolite from the marine myxobacterium Haliangium ochraceum","volume":"21","author":"Sun","year":"2016","journal-title":"Molecules"},{"issue":"49","key":"10.1016\/j.neuro.2018.02.017_bib0685","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1002\/anie.201406973","article-title":"Disciformycins A and B: 12\u2010Membered macrolide glycoside antibiotics from the Myxobacterium Pyxidicoccus fallax Active against Multiresistant Staphylococci","volume":"53","author":"Surup","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0690","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/anie.201309386","article-title":"Structure elucidation and total synthesis of kulkenon","volume":"53","author":"Symkenberg","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0695","first-page":"659","article-title":"Antibiotika aus Gleitenden Bakterien, 45. Phenalamide, neue HIV-1-Inhibitoren aus Myxococcus stipitatus Mx s40","volume":"1992","author":"Trowitzsch-Kienast","year":"1992","journal-title":"Eur. J. Org. Chem."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0700","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00309532","article-title":"Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A","volume":"25","author":"Vahlensieck","year":"1994","journal-title":"Curr. Genet."},{"issue":"10","key":"10.1016\/j.neuro.2018.02.017_bib0705","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/AAC.00369-07","article-title":"The antifungal polyketide ambruticin targets the HOG pathway","volume":"51","author":"Vetcher","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0710","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eurpsy.2003.03.003","article-title":"Number of dementia sufferers in Europe between the years 2000 and 2050","volume":"18","author":"Wancata","year":"2003","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuro.2018.02.017_bib0715","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/1381612053764742","article-title":"The Epothilones and related analogues-A review of their syntheses and anti-cancer activities","volume":"11","author":"Watkins","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0720","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.bmc.2008.11.025","article-title":"A brief tour of myxobacterial secondary metabolism","volume":"17","author":"Weissman","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.neuro.2018.02.017_bib0725","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1039\/c001260m","article-title":"Myxobacterial secondary metabolites: bioactivities and modes-of-action","volume":"27","author":"Weissman","year":"2010","journal-title":"Nat. Prod. Rep."},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0730","first-page":"220","article-title":"The biosynthetic potential of myxobacteria and their impact in drug discovery","volume":"12","author":"Wenzel","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"issue":"1","key":"10.1016\/j.neuro.2018.02.017_bib0735","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mrm.1910370107","article-title":"In vivo measurement of T2 distributions and water contents in normal human brain","volume":"37","author":"Whittall","year":"1997","journal-title":"Magnet. Reson. Med."},{"issue":"8","key":"10.1016\/j.neuro.2018.02.017_bib0740","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.jnatprod.5b00118","article-title":"Synthesis and characterization of 5-hydroxy-2-(2-phenylethyl) chromone (5-HPEC) and its analogues as non-nitrogenous 5-ht2b ligands","volume":"78","author":"Williams","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"12","key":"10.1016\/j.neuro.2018.02.017_bib0745","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1371\/journal.pcbi.0030253","article-title":"Social interactions in myxobacterial swarming","volume":"3","author":"Wu","year":"2007","journal-title":"PLoS Computat. Biol."},{"issue":"18","key":"10.1016\/j.neuro.2018.02.017_bib0750","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1128\/JB.05052-11","article-title":"Antibiotic production by myxobacteria plays a role in predation","volume":"193","author":"Xiao","year":"2011","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.neuro.2018.02.017_bib0755","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1128\/aem.63.7.2572-2577.1997","article-title":"Distribution of polyunsaturated fatty acids in bacteria present in intestines of deep-sea fish and shallow-sea poikilothermic animals","volume":"63","author":"Yano","year":"1997","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.11.004","article-title":"The early events of Alzheimer\u2019s disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits","volume":"33","author":"Ye","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuro.2018.02.017_bib0765","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/AAC.19.2.349","article-title":"Mode of action of Myxococcus xanthus antibiotic TA","volume":"19","author":"Zafriri","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"issue":"28","key":"10.1016\/j.neuro.2018.02.017_bib0770","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1002\/chem.201003677","article-title":"Roimatacene: an antibiotic against gram\u2010negative bacteria isolated from Cystobacter ferrugineus Cb G35 (Myxobacteria)","volume":"17","author":"Zander","year":"2011","journal-title":"Chem.-Eur. J."},{"issue":"6","key":"10.1016\/j.neuro.2018.02.017_bib0775","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/np1006789","article-title":"P-hydroxyacetophenone amides from Cystobacter ferrugineus, strain Cb G35","volume":"74","author":"Zander","year":"2011","journal-title":"J. Nat. Products"},{"issue":"11","key":"10.1016\/j.neuro.2018.02.017_bib0780","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","article-title":"The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18300585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18300585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:20:27Z","timestamp":1758982827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X18300585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":156,"alternative-id":["S0161813X18300585"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2018.02.017","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myxobacterial natural products: An under-valued source of products for drug discovery for neurological disorders","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2018.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}